Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Rusch
    Rusch
  3. Wu
    Wu
  4. Kollmeier
    Kollmeier
  5. Travis
    Travis
  6. Kris
    Kris
  7. Riely
    Riely
  8. Alektiar
    Alektiar
  9. Abu-Rustum
    Abu-Rustum
  10. Jakubowski
    Jakubowski

Groups

  1. Department of Medicine (207)
  2. Surgery (145)
  3. Survivorship Research (130)
  4. Solid Tumor Oncology Division (123)
  5. Radiation Oncology, Department of (93)
  6. GSK Faculty (82)
  7. Center for Hematologic Malignancies (80)
  8. Hematologic Malignancies, Division of (73)
  9. Gynecology Disease Management Team (52)
  10. Epidemiology and Biostatistics (51)
Search Within
  1. "2013"
Formats
  1. Journal Article (257)
  2. Meeting Abstract (224)
  3. Book Section (21)
Groups
  1. Department of Medicine (207)
  2. Surgery (145)
  3. Survivorship Research (130)
  4. Solid Tumor Oncology Division (123)
  5. Radiation Oncology, Department of (93)
  6. GSK Faculty (82)

More Groups

People
  1. Sergio Giralt (34)
  2. Abraham Wu (23)
  3. Valerie Rusch (23)
  4. Camelia Sima (20)
  5. Andreas Rimner (19)
  6. Marisa Kollmeier (19)

More People

Years
  1. 2013 (502)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (88)
  2. Journal of Thoracic Oncology (72)
  3. Biology of Blood and Marrow Transplantation (59)
  4. European Journal of Cancer (53)
  5. Gynecologic Oncology (28)
  6. Journal of Sexual Medicine (18)

More Publications

Results (502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Spread through alveolar spaces (STAS): A newly recognized pattern of invasion in lung adenocarcinoma associated with increased recurrence in patients undergoing limited resection for <= 2cm tumors
    Meeting Abstract

    Nitadori, J.; Kadota, K.; Sima, C. S.; Ujiie, H.; Rizk, N. P.; Rusch, V. W.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Digital microscopy reproducibility study of thymic epithelial neoplasms
    Meeting Abstract

    Moreira, A. L.; Wang, H.; Sima, C. S.; Beasley, M. B.; Illei, P.; Saqi, A.; Nonaka, D.; Geisinger, K.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors
    Meeting Abstract

    Modh, A.; Williams, E.; Rimner, A.; Foster, A.; Yorke, E.; Jackson, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Determining read origin of next-generation sequencing datasets from lung cancer xenografts
    Meeting Abstract

    Marini, K.; Tothill, R.; Britt, K.; Falzon, J.; Li, J.; Bennett, S.; Tantoso, E.; Brown, T. J.; Martelotto, L.; Watkins, N.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Using synthetic lethal screening to identify therapeutic targets for innately platinum resistant lung cancer
    Meeting Abstract

    Marini, K.; Rossello, F.; Martelotto, L.; Watkins, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Inhibition of the IGF-1R signaling pathway potentiates responses to ALK inhibitors in both ALK TKI naive and ALK TKI resistant lung cancer
    Meeting Abstract

    Lovly, C. M.; McDonald, N. T.; Chen, Y. L. H.; Jin, H. L.; Lim, D.; Suehara, Y.; Wang, L.; Johnson, D. H.; Horn, L.; Ladanyi, M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy
    Meeting Abstract

    Lee, M. C.; Kadota, K.; Ujiie, H.; Rizk, N. P.; Travis, W. D.; Rusch, V. W.; Sadelain, M.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Pilot trial of an adjuvant pentavalent vaccine for patients with small cell lung cancer (SCLC)
    Meeting Abstract

    Krug, L. M.; Varghese, A.; Ragupathi, G.; George, C.; Sawada, R.; Scholz, W. W.; Hansen, D.; Livingston, P. O.; Delasos, L.; Pietanza, M. C.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Treatment with therapies matched to oncogenic drivers improves survival in patients with lung cancers: Results from the Lung Cancer Mutation Consortium (LCMC)
    Meeting Abstract

    Kris, M. G.; Johnson, B.; Berry, L.; Kwiatkowski, D.; Iafrate, A. J.; Wistuba, I.; Varella-Garcia, M.; Franklin, W.; Aronson, S.; Su, P. F.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Results with dacomitinib (PF-00299804), an irreversible PAN-HER tyrosine kinase inhibitor, in a phase II cohort of patients with HER2-mutant or amplified lung cancers
    Meeting Abstract

    Kris, M. G.; Camidge, D. R.; Giaccone, G.; Hida, T.; O'Connell, J.; Taylor, I.; Zhang, H.; Gold-Berg, Z.; Jänne, P. A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save